JPS6338190B2 - - Google Patents
Info
- Publication number
- JPS6338190B2 JPS6338190B2 JP60112285A JP11228585A JPS6338190B2 JP S6338190 B2 JPS6338190 B2 JP S6338190B2 JP 60112285 A JP60112285 A JP 60112285A JP 11228585 A JP11228585 A JP 11228585A JP S6338190 B2 JPS6338190 B2 JP S6338190B2
- Authority
- JP
- Japan
- Prior art keywords
- medium
- cells
- glutamine
- heat
- sterilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000004102 animal cell Anatomy 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 6
- 108010016626 Dipeptides Proteins 0.000 claims description 5
- 150000008575 L-amino acids Chemical group 0.000 claims description 2
- 210000004027 cell Anatomy 0.000 description 21
- 239000002609 medium Substances 0.000 description 19
- 230000001954 sterilising effect Effects 0.000 description 10
- 238000004659 sterilization and disinfection Methods 0.000 description 10
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 8
- 229930182816 L-glutamine Natural products 0.000 description 7
- 229940024606 amino acid Drugs 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 4
- 235000017557 sodium bicarbonate Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 150000008540 L-glutamines Chemical class 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 238000004113 cell culture Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229950010030 dl-alanine Drugs 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- PNMUAGGSDZXTHX-BYPYZUCNSA-N Gly-Gln Chemical compound NCC(=O)N[C@H](C(O)=O)CCC(N)=O PNMUAGGSDZXTHX-BYPYZUCNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- KSMRODHGGIIXDV-YFKPBYRVSA-N N-acetyl-L-glutamine Chemical compound CC(=O)N[C@H](C(O)=O)CCC(N)=O KSMRODHGGIIXDV-YFKPBYRVSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 229960002648 alanylglutamine Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- SEACYXSIPDVVMV-UHFFFAOYSA-L eosin Y Chemical compound [Na+].[Na+].[O-]C(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C([O-])=C(Br)C=C21 SEACYXSIPDVVMV-UHFFFAOYSA-L 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 108010010147 glycylglutamine Proteins 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 238000012007 large scale cell culture Methods 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000011146 sterile filtration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60112285A JPS61271985A (ja) | 1985-05-27 | 1985-05-27 | 培地 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60112285A JPS61271985A (ja) | 1985-05-27 | 1985-05-27 | 培地 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61271985A JPS61271985A (ja) | 1986-12-02 |
| JPS6338190B2 true JPS6338190B2 (enrdf_load_stackoverflow) | 1988-07-28 |
Family
ID=14582864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60112285A Granted JPS61271985A (ja) | 1985-05-27 | 1985-05-27 | 培地 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61271985A (enrdf_load_stackoverflow) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130130317A1 (en) | 2010-08-02 | 2013-05-23 | Kyowa Hakko Kirin Co., Ltd | Method for producing substance |
| DE102017203908B3 (de) | 2017-03-09 | 2018-05-30 | Evonik Technochemie Gmbh | Kulturmedium, umfassend Oligopeptide |
| DK3372670T3 (da) | 2017-03-09 | 2019-05-20 | Evonik Technochemie Gmbh | Dyrkningsmedier, der omfatter n-acyl-x-glutamindipeptider |
-
1985
- 1985-05-27 JP JP60112285A patent/JPS61271985A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS61271985A (ja) | 1986-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0545946B1 (en) | Growth-promoting agent | |
| US4849329A (en) | Process for preparing lymphokine activated killer cells | |
| CN110101864A (zh) | 一种无血清人用狂犬病疫苗的保护剂及其应用 | |
| Bader et al. | LATENT VIRAL INFECTION OF CELLS IN TISSUE CULTURE: VI. Role of Amino Acids, Glutamine, and Glucose in Psittacosis Virus Propagation in L Cells | |
| Minamoto et al. | Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture | |
| Baker et al. | Effect of the amino acids and dialyzable constituents of embryonic tissue juice on the growth of fibroblasts | |
| JPS6338190B2 (enrdf_load_stackoverflow) | ||
| US5468635A (en) | In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme | |
| RU2662172C2 (ru) | Способ получения регенеративного ветеринарного препарата на основе экстракта мезенхимальных стволовых клеток и кондиционной среды | |
| CN115537442A (zh) | 一种蛋黄磷酸肽及其高效富集制备方法与应用 | |
| JP2824254B2 (ja) | 線維芽細胞増殖物質 | |
| Palotie et al. | Effect of the structural components of basement membranes on the attachment of teratocarcinoma-derived endodermal cells | |
| CN110804579A (zh) | 慢病毒载体制备用293t细胞培养基及其制备方法 | |
| JP2800338B2 (ja) | 細胞培養用無血清培地の調製方法 | |
| EP0396402A2 (en) | Cell growth activators | |
| JPS6326988B2 (enrdf_load_stackoverflow) | ||
| JPS6030508B2 (ja) | 細胞培養用容器 | |
| RU2066995C1 (ru) | Способ получения препарата, стимулирующего клеточное дыхание | |
| JPH03201980A (ja) | 細胞培養用無血清培地 | |
| JPS63188697A (ja) | 牛脾臓由来の細胞増殖促進物質 | |
| JPS6087785A (ja) | 動物細胞用無血清培地の殺菌調製方法 | |
| Ito et al. | The growth-stimulating activity of peptides on human hematopoietic cell cultures | |
| JPH0947284A (ja) | 動物細胞の培養方法 | |
| JPH0866184A (ja) | 接着性動物細胞の浮遊培養のための無血清培地及びこれを用いた浮遊培養方法 | |
| Oberley et al. | The growth of primary glomerular cells as a confluent monolayer in a chemically defined serum-free medium: specific requirements for prostaglandins and extracellular matrix molecules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |